Scalp Treatment

IDS Clinic's scalp treatments address scalp health concerns including dandruff, seborrhoeic dermatitis, scalp inflammation, and early-stage hair thinning. Procedural options include scalp mesotherapy with targeted nutrients and growth factors to improve follicular health and reduce hair shedding.

A healthy scalp is the foundation for healthy hair growth, and IDS Clinic's scalp treatment programme addresses both cosmetic and medical scalp concerns that can contribute to hair loss, thinning, and impaired regrowth. The programme is complementary to hair loss consultations and can serve as a standalone maintenance protocol for patients seeking to optimise scalp health preventively. Scalp mesotherapy is a key procedural offering, involving the microinjection of a customised cocktail of vitamins, minerals, amino acids, and growth factors directly into the scalp dermis. This targeted nutrient delivery bypasses systemic absorption, ensuring high local concentrations of active ingredients in the environment surrounding the hair follicles. Common actives used include biotin (vitamin B7), zinc, selenium, copper, minoxidil, and DHT-blocking agents. Mesotherapy is well-suited for patients with diffuse hair thinning, telogen effluvium, or those seeking to enhance results following FUE hair transplantation. For patients with scalp inflammation — a significant contributor to follicular miniaturisation in androgenetic alopecia — the clinic offers targeted anti-inflammatory protocols including topical prescription agents and, in some cases, low-dose intralesional corticosteroid injections for conditions such as alopecia areata or lichen planopilaris. Seborrhoeic dermatitis and chronic dandruff, caused by the Malassezia yeast, are managed with medicated shampoos (zinc pyrithione, ketoconazole, selenium sulphide) and topical antifungal preparations, with dermatologist-level oversight distinguishing IDS Clinic's scalp care from standard salon treatments. Low-level laser therapy (LLLT) is another evidence-supported modality available for in-clinic and at-home use, using specific red-light wavelengths (typically 650–670 nm) to stimulate follicular activity through photobiomodulation. LLLT has demonstrated benefit in both male and female pattern hair loss when used consistently over 16 to 26 weeks. The clinic integrates LLLT into comprehensive scalp health plans for patients who prefer a non-pharmacological adjunct to their hair loss management.